Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Equity Average (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Equity Average for 6 consecutive years, with $38.8 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 51.46% to $38.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.8 million through Dec 2025, down 51.46% year-over-year, with the annual reading at $54.3 million for FY2025, 43.85% down from the prior year.
  • Equity Average hit $38.8 million in Q4 2025 for Rapid Micro Biosystems, down from $49.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $227.9 million in Q4 2021 to a low of -$157.8 million in Q2 2021.
  • Historically, Equity Average has averaged $95.0 million across 5 years, with a median of $106.1 million in 2024.
  • Biggest five-year swings in Equity Average: skyrocketed 432.6% in 2022 and later tumbled 51.46% in 2025.
  • Year by year, Equity Average stood at $227.9 million in 2021, then dropped by 24.69% to $171.6 million in 2022, then dropped by 28.38% to $122.9 million in 2023, then crashed by 35.01% to $79.9 million in 2024, then plummeted by 51.46% to $38.8 million in 2025.
  • Business Quant data shows Equity Average for RPID at $38.8 million in Q4 2025, $49.4 million in Q3 2025, and $60.0 million in Q2 2025.